Search
BioCryst Pharmaceuticals Inc
BCRXAdd to Watchlist
9.650USD
-0.350-3.50%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.45BMarket Cap
LossP/E TTM
BioCryst Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
874.84M
94.10%
EPS(YoY)
1.26
392.35%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 874.84M, with a year-on-year change of 94.10.
What are the current assets of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its current assets were 404.35M, with a year-on-year change of -4.18.
What are the total assets of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total assets of BioCryst Pharmaceuticals Inc were 514.16M, with a year-on-year change of 4.84.
What are the total liabilities of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of BioCryst Pharmaceuticals Inc were 633.31M, with a year-on-year change of -34.46.
What is the total equity of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total equity of BioCryst Pharmaceuticals Inc was -119.15M, with a year-on-year change of 74.96.
What is the net investment of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net investment of BioCryst Pharmaceuticals Inc was -13.69M, with a year-on-year change of -126.04.
What is the net financing of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net financing of BioCryst Pharmaceuticals Inc was -349.93M, with a year-on-year change of -5974.14.
What is the Earnings Per Share (EPS) of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.26, with a year-on-year change of 392.35.
What is the net margin of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 30.16, with a year-on-year change of 252.95.
What is the gross margin of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 97.82, with a year-on-year change of 0.61.
What is the debt-to-asset ratio of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 91.11, with a year-on-year change of -46.33.
What is the Return on Assets (ROA) of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 52.53, with a year-on-year change of 397.70.
What is the operating profit of BioCryst Pharmaceuticals Inc?
According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 340.99M, with a year-on-year change of 13508.93.